Research explained: randomized double-blind crossover trial
Monk fruit sweetener blends raised blood sugar and insulin less than table sugar in a small crossover trial
In a randomized double-blind study of 30 healthy adults, three monk fruit-based blends gave smaller glucose and insulin responses than sucrose after the drink, with no difference in appetite or energy intake, but more diarrhea.
Drinks sweetened with monk fruit-based blends produced smaller rises in blood glucose and insulin than drinks sweetened with table sugar, according to a small randomized trial of 30 healthy adults published on October 31, 2026 in the European Journal of Nutrition. The gap showed up in the period after the drink. Once participants ate a standardized meal, responses were comparable across all the sweeteners. Appetite and energy intake did not differ, while diarrhea was more frequent with the monk fruit blends.
What the researchers did
A team at Chiang Mai University in Thailand tested three monk fruit-based formulations, made from natural ingredients including fructooligosaccharides and designed to be equally sweet. They compared these with sucrose and sucralose in five test sessions, each with a sweetened drink followed by a standardized meal. Plasma glucose and serum insulin were measured over 180 minutes. Appetite, liking and wanting, energy intake and side effects were secondary outcomes.
Sucralose, like the monk fruit blends, gave lower responses than sucrose after the drink. Overall glucose and insulin responses were lower for the monk fruit blends. One blend scored lower on liking and wanting. Side effects were mild.
How strong is the evidence?
Randomized, double-blind crossover trials are a strong way to compare foods, because each person tries every option. The study was also registered before it began. Its limits are the small size, the healthy participants and the short test window, so it cannot say what happens with regular use over months or in people with diabetes.
Conflicts matter here. Chiang Mai University has been granted a petty patent on these formulations, and two of the authors are listed as inventors. The other authors declare no known competing financial interests. The abstract does not report funding.
What it means for you
If you want a sweetener with a smaller short-term effect on blood glucose than sugar, this trial adds some support for these monk fruit blends, and it found the same pattern for sucralose. The results apply to the tested formulations, and a stomach upset is possible, so notice how you feel if you try a similar product. You can compare other options on the pages for honey, maple syrup and diet cola, or browse drinks.